Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.03T | 37x | 1.34 | CA$38.69 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | -2.68 | CA$24.86 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | -2.68 | CA$250.04 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.2% Upside | Upgrade to Pro+ | |
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | -2.68 | CA$22.81 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | -2.68 | CA$22.74 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | CA$21.38 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$77.54B | 25x | CA$249.76 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$61.45B | 28.9x | 3.83 | CA$204.56 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.2% Downside | Upgrade to Pro+ | |
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$22.40B | 23.5x | -10.48 | CA$101.61 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5% Downside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.31B | 17.1x | -2.27 | CA$48.37 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$2.44B | 18.6x | 11.79 | CA$51.01 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.94B | 23.8x | 0.18 | CA$8.21 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$359.80M | -23x | -0.28 | CA$6.97 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$330.23M | -0.6x | 0 | CA$0.86 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$231.80M | -1.6x | -0.09 | CA$0.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$231.80M | -1.6x | -0.09 | CA$0.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$221.77M | -34.3x | -0.41 | CA$2.75 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$165.78M | -38x | -1.84 | CA$2.67 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.6% Upside | Upgrade to Pro+ | |
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$113.81M | -1.5x | -0.04 | CA$0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$113.81M | -1.5x | -0.04 | CA$0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$96.91M | 47.5x | -0.86 | CA$0.95 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$59.80M | -30x | 0.86 | CA$0.49 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$51.98M | -3.2x | -0.11 | CA$0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$28.32M | 0.02 | CA$0.24 | -17.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$22.74M | -2.3x | -0.09 | CA$0.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$15.65M | -0.1x | 0 | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanadaBis Capital | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$13.13M | 61.2x | -0.65 | CA$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$12.58M | -11.6x | -0.18 | CA$0.09 | -58.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.74M | -0.1x | -0.01 | CA$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nass Valley Gateway | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.62M | -7.5x | CA$0.04 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$6.98M | -0.5x | -0.01 | CA$2.20 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$6.84M | -0.8x | -0.02 | CA$0.04 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$6.84M | -0.8x | -0.02 | CA$0.04 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.95M | -4.7x | -0.09 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.78M | -10x | 0.07 | CA$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ORAGIN Foods | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$3.12M | -1x | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Entourage Health | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.54M | -0x | -0 | CA$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$756.78K | -4.9x | -0.1 | CA$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kiaro Holdings | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$221.07K | -0x | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |